Kenanga downgrades Pharmaniaga to underperform, slashes TP to RM1.60
1 min read
KUALA LUMPUR: Kenanga research has downgraded Pharmaniaga Bhd from market perform to underperform after slashing its FY20 net profit forecast by 32% on an expected 18% contraction in revenue.
